Anterix (ATEX) Change in Accured Expenses (2016 - 2025)

Anterix filings provide 12 years of Change in Accured Expenses readings, the most recent being -$3.7 million for Q4 2025.

  • On a quarterly basis, Change in Accured Expenses fell 292.81% to -$3.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.4 million, a 294.66% decrease, with the full-year FY2025 number at $550000.0, down 71.59% from a year prior.
  • Change in Accured Expenses hit -$3.7 million in Q4 2025 for Anterix, down from $4.7 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $4.7 million in Q3 2025 to a low of -$3.7 million in Q4 2025.
  • Median Change in Accured Expenses over the past 5 years was $39500.0 (2023), compared with a mean of $3800.0.
  • Biggest five-year swings in Change in Accured Expenses: tumbled 872.58% in 2021 and later soared 22128.57% in 2025.
  • Anterix's Change in Accured Expenses stood at $2.1 million in 2021, then tumbled by 44.05% to $1.2 million in 2022, then grew by 3.32% to $1.2 million in 2023, then skyrocketed by 58.15% to $1.9 million in 2024, then plummeted by 292.81% to -$3.7 million in 2025.
  • The last three reported values for Change in Accured Expenses were -$3.7 million (Q4 2025), $4.7 million (Q3 2025), and -$2.6 million (Q2 2025) per Business Quant data.